Literature DB >> 28681200

MicroRNA expression signature of methamphetamine use and addiction in the rat nucleus accumbens.

Maw Shin Sim1, Tomoko Soga2, Vijayapandi Pandy3, Yuan Seng Wu3, Ishwar S Parhar2, Zahurin Mohamed4.   

Abstract

Methamphetamine (METH) is a highly addictive psycho-stimulant that induces behavioral changes due to high level of METH-induced dopamine in the brain. Nucleus accumbens (NAc) plays an important role in these changes, especially in drug addiction. However, little is known about the underlying molecular mechanisms of METH-induced addiction. The objective of this study was to establish a behavioral model of METH use and addiction using escalating doses of METH over 15 days and to determine the global miRNA expression profiling in NAc of METH-addicted rats. In the behavioral study, the experimental rats were divided into 3 groups of 9 each: a control group, a single dose METH (5 mg/kg) treatment group and a continuous 15 alternate days METH (0.25, 0.5, 1, 2, 3, 4, 5 mg/kg) treatment group. Following that, six rats in each group were randomly selected for global miRNA profiling. Addiction behavior in rats was established using Conditioned Place Preference task. The analysis of the miRNA profiling in the NAc was performed using Affymetric microarray GeneChip® System. The findings indicated that a continuous 15 alternate days METH treatment rats showed a preference for the drug-paired compartment of the CPP. However, a one-time acute treatment with 5 mg/kg METH did not show any significant difference in preference when compared with controls. Differential profiling of miRNAs indicated that 166 miRNAs were up-regulated and 4 down-regulated in the chronic METH-treatment group when compared to controls. In comparing the chronic treatment group with the acute treatment group, 52 miRNAs were shown to be up-regulated and 7 were down-regulated. MiRNAs including miR-496-3p, miR-194-5p, miR-200b-3p and miR-181a-5p, were found to be significantly associated with METH addiction. Canonical pathway analysis revealed that a high number of METH addiction-related miRNAs play important roles in the MAPK, CREB, G-Protein Couple Receptor and GnRH Signaling pathways. Our results suggest that dynamic changes occur in the expression of miRNAs following METH exposure and addiction.

Entities:  

Keywords:  Methamphetamine; addiction; microRNA; nucleus accumbens; profiling

Mesh:

Substances:

Year:  2017        PMID: 28681200     DOI: 10.1007/s11011-017-0061-x

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  93 in total

1.  Overexpression of CREB in the nucleus accumbens shell increases cocaine reinforcement in self-administering rats.

Authors:  Erin B Larson; Danielle L Graham; Rose R Arzaga; Nicole Buzin; Joseph Webb; Thomas A Green; Caroline E Bass; Rachael L Neve; Ernest F Terwilliger; Eric J Nestler; David W Self
Journal:  J Neurosci       Date:  2011-11-09       Impact factor: 6.167

2.  The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing.

Authors:  Eugene V Makeyev; Jiangwen Zhang; Monica A Carrasco; Tom Maniatis
Journal:  Mol Cell       Date:  2007-08-03       Impact factor: 17.970

3.  microRNAs miR-124, let-7d and miR-181a regulate cocaine-induced plasticity.

Authors:  Vijay Chandrasekar; Jean-Luc Dreyer
Journal:  Mol Cell Neurosci       Date:  2009-08-22       Impact factor: 4.314

Review 4.  microRNAs at the synapse.

Authors:  Gerhard Schratt
Journal:  Nat Rev Neurosci       Date:  2009-11-04       Impact factor: 34.870

Review 5.  Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues.

Authors:  T M Tzschentke
Journal:  Prog Neurobiol       Date:  1998-12       Impact factor: 11.685

6.  A single cocaine exposure increases BDNF and D3 receptor expression: implications for drug-conditioning.

Authors:  Bernard Le Foll; Jorge Diaz; Pierre Sokoloff
Journal:  Neuroreport       Date:  2005-02-08       Impact factor: 1.837

7.  Essential role of SIRT1 signaling in the nucleus accumbens in cocaine and morphine action.

Authors:  Deveroux Ferguson; Ja Wook Koo; Jian Feng; Elizabeth Heller; Jacqui Rabkin; Mitra Heshmati; William Renthal; Rachael Neve; Xiaochuan Liu; Ningyi Shao; Vittorio Sartorelli; Li Shen; Eric J Nestler
Journal:  J Neurosci       Date:  2013-10-09       Impact factor: 6.167

8.  The expression of the Alzheimer's amyloid precursor protein-like gene is regulated by developmental timing microRNAs and their targets in Caenorhabditis elegans.

Authors:  Ryusuke Niwa; Feng Zhou; Chris Li; Frank J Slack
Journal:  Dev Biol       Date:  2008-01-08       Impact factor: 3.582

9.  A microRNA-based gene dysregulation pathway in Huntington's disease.

Authors:  Rory Johnson; Chiara Zuccato; Nikolai D Belyaev; Deborah J Guest; Elena Cattaneo; Noel J Buckley
Journal:  Neurobiol Dis       Date:  2007-11-13       Impact factor: 5.996

10.  Integrated miRNA-mRNA analysis in the habenula nuclei of mice intravenously self-administering nicotine.

Authors:  Sangjoon Lee; Jiwan Woo; Yong Sik Kim; Heh-In Im
Journal:  Sci Rep       Date:  2015-08-11       Impact factor: 4.379

View more
  17 in total

Review 1.  Non-coding RNA: insights into the mechanism of methamphetamine neurotoxicity.

Authors:  Ying-Jian Gu; Lei Chen; Lin Cheng; Ming-Yuan Zhou; Yun Wang
Journal:  Mol Cell Biochem       Date:  2021-04-25       Impact factor: 3.396

2.  Mechanisms underlying microRNA-222-3p modulation of methamphetamine-induced conditioned place preference in the nucleus accumbens in mice.

Authors:  Qing Shang; Jing Wang; Zhijia Xi; Baoyao Gao; Hongyan Qian; Ran An; Gaojie Shao; Hua Liu; Tao Li; Xinshe Liu
Journal:  Psychopharmacology (Berl)       Date:  2022-07-26       Impact factor: 4.415

3.  Different doses of methamphetamine alter long-term potentiation, level of BDNF and neuronal apoptosis in the hippocampus of reinstated rats.

Authors:  Siamak Shahidi; Alireza Komaki; Reihaneh Sadeghian; Sara Soleimani Asl
Journal:  J Physiol Sci       Date:  2019-01-24       Impact factor: 2.781

Review 4.  Role of microRNAs in the pathophysiology of addiction.

Authors:  Austin M Gowen; Katherine E Odegaard; Jordan Hernandez; Subhash Chand; Sneh Koul; Gurudutt Pendyala; Sowmya V Yelamanchili
Journal:  Wiley Interdiscip Rev RNA       Date:  2020-12-17       Impact factor: 9.957

Review 5.  Brain and Cognition for Addiction Medicine: From Prevention to Recovery Neural Substrates for Treatment of Psychostimulant-Induced Cognitive Deficits.

Authors:  Manoranjan S D'Souza
Journal:  Front Psychiatry       Date:  2019-07-24       Impact factor: 4.157

6.  Regional Analysis of the Brain Transcriptome in Mice Bred for High and Low Methamphetamine Consumption.

Authors:  Robert Hitzemann; Ovidiu D Iancu; Cheryl Reed; Harue Baba; Denesa R Lockwood; Tamara J Phillips
Journal:  Brain Sci       Date:  2019-06-30

7.  Association of GDNF and CNTNAP2 gene variants with gambling.

Authors:  Arundhuti Das; Luca Pagliaroli; Andrea Vereczkei; Eszter Kotyuk; Banrida Langstieh; Zsolt Demetrovics; Csaba Barta
Journal:  J Behav Addict       Date:  2019-08-26       Impact factor: 6.756

8.  Differential expression of microRNAs in the hippocampi of male and female rodents after chronic alcohol administration.

Authors:  Mi Ran Choi; Jasmin Sanghyun Han; Yeung-Bae Jin; Sang-Rae Lee; In Young Choi; Heejin Lee; Hyun Cho; Dai-Jin Kim
Journal:  Biol Sex Differ       Date:  2020-11-23       Impact factor: 5.027

Review 9.  An epigenetic, transgenerational model of increased mental health disorders in children, adolescents and young adults.

Authors:  Anthony P Monaco
Journal:  Eur J Hum Genet       Date:  2020-09-18       Impact factor: 4.246

10.  Methamphetamine use alters human plasma extracellular vesicles and their microRNA cargo: An exploratory study.

Authors:  Ursula S Sandau; Erika Duggan; Xiao Shi; Sierra J Smith; Marilyn Huckans; William E Schutzer; Jennifer M Loftis; Aaron Janowsky; John P Nolan; Julie A Saugstad
Journal:  J Extracell Vesicles       Date:  2020-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.